Who are Dexketoprofen/Vitamin B's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Acetaminophen & Indomethacin, Dexketoprofen Trometamol + Paracetamol, Pranoprofen Eyedrops, Non- effervescent Paracetamol kern, Diclofenac diethylamine 1.16% gel, Naproxen Sodium + Codeine Phosphate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dexketoprofen-vitamin-b.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Dexketoprofen/Vitamin B — Competitive Intelligence Brief

Dexketoprofen/Vitamin B (Dexketoprofen/Vitamin B) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID with vitamin supplement. Area: Pain Management / Rheumatology.

phase 3 NSAID with vitamin supplement COX-1, COX-2 Pain Management / Rheumatology Small molecule Live · refreshed every 30 min

Target snapshot

Dexketoprofen/Vitamin B (Dexketoprofen/Vitamin B) — Laboratorios Silanes S.A. de C.V.. Dexketoprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation, while vitamin B provides nutritional support and may enhance analgesic efficacy.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Dexketoprofen/Vitamin B TARGET	Dexketoprofen/Vitamin B	Laboratorios Silanes S.A. de C.V.	phase 3	NSAID with vitamin supplement	COX-1, COX-2
Acetaminophen & Indomethacin	Acetaminophen & Indomethacin	Queen's University	marketed	Analgesic/Anti-inflammatory combination	COX-1, COX-2 (indomethacin); central nervous system analgesic pathways (acetaminophen)
Dexketoprofen Trometamol + Paracetamol	Dexketoprofen Trometamol + Paracetamol	Yuzuncu Yil University	marketed	NSAID + analgesic combination	COX-1, COX-2 (dexketoprofen); central prostaglandin synthesis and pain pathways (paracetamol)
Pranoprofen Eyedrops	Pranoprofen Eyedrops	Università degli Studi di Brescia	marketed	Nonsteroidal anti-inflammatory drug (NSAID)	Cyclooxygenase (COX-1, COX-2)
Non- effervescent Paracetamol kern	Non- effervescent Paracetamol kern	Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina	marketed	Analgesic and antipyretic	Cyclooxygenase (COX-1, COX-2)
Diclofenac diethylamine 1.16% gel	Diclofenac diethylamine 1.16% gel	Novartis	marketed	NSAID (nonsteroidal anti-inflammatory drug)	COX-1, COX-2
Naproxen Sodium + Codeine Phosphate	Naproxen Sodium + Codeine Phosphate	ibrahim doğru	marketed	NSAID + opioid analgesic combination	COX-1, COX-2, mu-opioid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (NSAID with vitamin supplement class)

Laboratorios Silanes S.A. de C.V. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dexketoprofen/Vitamin B — Competitive Intelligence Brief. https://druglandscape.com/ci/dexketoprofen-vitamin-b. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab